Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1959 Feb;22(1):11–32. doi: 10.1136/jnnp.22.1.11

SOME ASPECTS OF THE EFFECTS OF ACUTE RESERPINE TREATMENT ON BEHAVIOUR

Peter H Glow 1
PMCID: PMC497344  PMID: 13642073

Full text

PDF
11

Images in this article

12Image
on p.12
12Image
on p.12
13Image
on p.13
13Image
on p.13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMBACHE N. The use and limitations of atropine for pharmacological studies on autonomic effectors. Pharmacol Rev. 1955 Dec;7(4):467–494. [PubMed] [Google Scholar]
  2. ANAND B. K., DUA S., MALHOTRA C. L. Effects of reserpine on blood-pressure responses evoked from the hypothalamus. Br J Pharmacol Chemother. 1957 Mar;12(1):8–11. doi: 10.1111/j.1476-5381.1957.tb01353.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BEIN H. J. The pharmacology of Rauwolfia. Pharmacol Rev. 1956 Sep;8(3):435–483. [PubMed] [Google Scholar]
  4. BRODIE B. B., SHORE P. A. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci. 1957 Mar 14;66(3):631–642. doi: 10.1111/j.1749-6632.1957.tb40753.x. [DOI] [PubMed] [Google Scholar]
  5. BRUCE H. M., PARKES A. S. Feeding and breeding of laboratory animals; a complete cubed diet for mice and rats. J Hyg (Lond) 1949 Jun;47(2):202–208. doi: 10.1017/s0022172400014479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HARDISTY R. M., INGRAM G. I., STACEY R. S. Reserpine and human platelet 5-hydroxytryptamine. Experientia. 1956 Nov 15;12(11):424–425. doi: 10.1007/BF02157365. [DOI] [PubMed] [Google Scholar]
  7. ISBELL H., LOGAN C. R. Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction. AMA Arch Neurol Psychiatry. 1957 Apr;77(4):350–358. doi: 10.1001/archneurpsyc.1957.02330340026002. [DOI] [PubMed] [Google Scholar]
  8. JENKNER F. L., WARD A., Jr Bulbar reticular formation and tremor. AMA Arch Neurol Psychiatry. 1953 Oct;70(4):489–502. [PubMed] [Google Scholar]
  9. KINROSS-WRIGHT V. Chlorpromazine and reserpine in the treatment of psychoses. Ann N Y Acad Sci. 1955 Apr 15;61(1):174–182. doi: 10.1111/j.1749-6632.1955.tb42464.x. [DOI] [PubMed] [Google Scholar]
  10. LESSIN A. W., PARKES M. W. The relation between sedation and body temperature in the mouse. Br J Pharmacol Chemother. 1957 Jun;12(2):245–250. doi: 10.1111/j.1476-5381.1957.tb00128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. PAASONEN M. K., VOGT M. The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain. J Physiol. 1956 Mar 28;131(3):617–626. doi: 10.1113/jphysiol.1956.sp005486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pembrey M. S. The Effect of Variations in External Temperature upon the Output of Carbonic Acid and the Temperature of Young Animals. J Physiol. 1895 Sep 5;18(4):363–379. doi: 10.1113/jphysiol.1895.sp000573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SHEPPARD H., LUCAS R. C., TSIEN W. H. The metabolism of reserpine-C14. Arch Int Pharmacodyn Ther. 1955 Oct 1;103(2-3):256–269. [PubMed] [Google Scholar]
  14. SIDMAN M. Drug-behavior interaction. Ann N Y Acad Sci. 1956 Nov 2;65(4):282–302. doi: 10.1111/j.1749-6632.1956.tb49640.x. [DOI] [PubMed] [Google Scholar]
  15. TASHER D. C., CHERMAK M. W. The use of reserpine in shock-reversible patients and shock-resistant patients. Ann N Y Acad Sci. 1955 Apr 15;61(1):108–116. doi: 10.1111/j.1749-6632.1955.tb42457.x. [DOI] [PubMed] [Google Scholar]
  16. WOOLLEY D. W., SHAW E. Some neurophysiological aspects of serotonin. Br Med J. 1954 Jul 17;2(4880):122–126. doi: 10.1136/bmj.2.4880.122. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES